Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment

Universal standardization for dual X-ray absorptiometry: Patient and phantom cross-calibration results

(2010) Harry K. Genant   JOURNAL OF BONE AND MINERAL RESEARCH

The diagnosis of osteoporosis

(2010) John A. Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®

(2009) John A. Kanis et al.   BONE

FRAX® and its applications to clinical practice

(2009) John A. Kanis et al.   BONE

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study

(2009) G. Ioannidis et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Population-based Canadian hip fracture rates with international comparisons

(2009) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

The effects of a FRAX® revision for the USA

(2009) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Updated fracture incidence rates for the US version of FRAX®

(2009) B. Ettinger et al.   OSTEOPOROSIS INTERNATIONAL

BMD, clinical risk factors and their combination for hip fracture prevention

(2009) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

(2009) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents

(2008) C. Berger et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines

(2008) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A Revised Clinician’s Guide to the Prevention and Treatment of Osteoporosis

(2008) Bess Dawson-Hughes   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)

(2008) S. Fujiwara et al.   OSTEOPOROSIS INTERNATIONAL

Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study

(2008) E. V. McCloskey et al.   OSTEOPOROSIS INTERNATIONAL

Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women

(2008) K. Lippuner et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effective osteoporosis treatment thresholds: the United States perspective

(2008) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

(2008) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

A reference standard for the description of osteoporosis

(2007) John A. Kanis et al.   BONE